INTERNATIONAL PATENT: JP BIO CORPORATION, 제이피바이오 주식회사 FILES APPLICATION FOR "PHARMACEUTICAL FORMULATION WITH IMPROVED STABILITY COMPRISING DAPAGLIFLOZIN, LINAGLIPTIN AND METFORMIN"

Posted On: 2025-11-04

GENEVA, Nov. 4 -- JP BIO CORPORATION ((Keumkang High Tech Valley 2cha, Sangdaewon-dong) 701, 159, Sagimakgol-ro, Jungwon-guSeongnam-siGyeonggi-do 13202), 제이피바이오 주식회사 (경기도성남시중원구 사기막골로 159, 701호 (금강하이테크밸리2차, 상대원동)) filed a patent application (PCT/KR2025/099768) for "PHARMACEUTICAL FORMULATION WITH IMPROVED STABILITY COMPRISING DAPAGLIFLOZIN, LINAGLIPTIN, AND METFORMIN" on Mar 13, 2025. With publication no. WO/2025/226138, the details related to the patent application was published ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: JP BIO CORPORATION, 제이피바이오 주식회사 FILES APPLICATION FOR "PHARMACEUTICAL FORMULATION WITH IMPROVED STABILITY COMPRISING DAPAGLIFLOZIN, LINAGLIPTIN AND METFORMIN"